We serve Chemical Name:(1R,2S)-cyclopropane-1,2-dicarbaldehyde CAS:50653-70-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(1R,2S)-cyclopropane-1,2-dicarbaldehyde
CAS.NO:50653-70-8
Synonyms:Cyclo-propan-cis-1,2-dicarbaldehyde;cis-Cyclopropan-dicarbaldehyd-(1,2);cis-cyclopropane-1,2-dicarbaldehyde
Molecular Formula:C5H6O2
Molecular Weight:98.09990
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:71 – 73 °C (7 mmHg)
Density:N/A
Index of Refraction:
PSA:34.14000
Exact Mass:98.03680
LogP:0.02030
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Cyclo-propan-cis-1,2-dicarbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,cis-cyclopropane-1,2-dicarbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cis-Cyclopropan-dicarbaldehyd-(1,2) Use and application,cis-cyclopropane-1,2-dicarbaldehyde technical grade,usp/ep/jp grade.
Related News: GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. N-(7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methyl-1,8-naphthyridine-3-carboxamide manufacturers J&J’s shot generates roughly 8 GBS cases per million vaccinated people, far higher than just a single case reported per million among mRNA recipients, CDC reported. (R)-1-(2-amino-2-phenylethyl)-3-(2-fluoro-3-methoxyphenyl)-5-(2-(trifluoromethyl)benzyl)-1,3,5-triazinane-2,4,6-trione suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. methyl exo-(1R,5S)-3-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2,6-difluorophenyl)-3-azabibyclo[3.1.0]hex-6-ylcarbamate vendor & factory.
